[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tnf Pharmaceuticals Inc (TNFA)

Tnf Pharmaceuticals Inc (TNFA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tnf Pharmaceuticals Inc 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 USA

https://tnfpharma.com Employees: 3 P: 856-848-8698

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

TNF Pharmaceuticals Inc. is a clinical stage pharmaceutical company committed to extending healthy lifespan. It focused on developing novel therapeutic platforms which treat the causes of disease rather than only addressing the symptoms. TNF Pharmaceuticals Inc., formerly known as MyMD Pharmaceuticals Inc., is based in BALTIMORE.

Key Statistics

Overview:

Market Capitalization, $K 9,604
Enterprise Value, $K 14,504
Shares Outstanding, K 1,847
Float, K 1,839
% Float 99.55%
Short Interest, K 311
Days to Cover 1.00
Short Volume Ratio 0.54
% of Insider Shareholders 0.45%
% of Institutional Shareholders 9.64%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -23,360 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,800 K
EBIT, $ -8,360 K
EBITDA, $ -8,260 K

Growth:

1-Year Return -96.12%
3-Year Return -99.93%
5-Year Return -99.96%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 97.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -18.00 on 08/19/25
Next Earnings Date 11/13/25
Earnings Per Share ttm -231.00
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 90.06%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 09/02/25

TNFA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -69.21%
Return-on-Assets % -33.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.30
Book Value/Share 18.21
Interest Coverage -2.47
60-Month Beta 2.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.